2. GSK’S Introduction GlaxoSmithKline often abbreviated to GSK, is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom.
3. GSK’S Introduction It is world’s third largest pharmaceutical company measured by revenues ( after Johnson and Johnson and Pfizer. It has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions.
4.
5.
6. Chairman: Sir Christopher Gent Chief Executive Officer: Andrew Witty
18. Two other companies Stiefel, a GSK company— A Global Leader in Dermatology ViiV Healthcare — a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people
22. World market by geographic region value(billion pounds) % of total USA 187 40 Europe 131 28 France 25 5 Germany 24 5 Italy 16 3 UK 12 3 Rest of World 150 32 Emerging markets 66 14 Asia Pacific 20 4 Japan 50 11 Canada 11 2
23. Regional analysis (2009) (2008) cer% pnd% USA 9,180 8,894 (13) 3 Europe 7,681 6,483 9 18 Emerging Markets 2,973 2,290 20 30 Asia Pacific/Japan 2,700 1,918 16 41 Other trading‡ 1,180 796 31 48 23,714 20,381 2 16
24. CER% represents growth at constant exchange rates. Pound % growth at actual exchange rates.
37. COMPETITORS IN JAPAN NAME OF THE COUNTRY TAKEDAPHARMACEUTICAL. ASTELLAS PHARMA DAIICHI SANKYO 9 EISAI CHUGAI PHARMACEUTICAL . TOTAL REVENUE (IN USD BILLIONS) 15.6 10.7 9 5.5 2.0